Articles by Eric Langer - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Eric Langer

Biomanufacturing Outlook

Industry optimism is on the rise for 2012.
Feb 2, 2012

Industry optimism is on the rise for 2012.

Biosimilars' Technology Needs

Biosimilar manufacturers need better expression systems and analytical tools to compete.
Dec 7, 2011

Biosimilar manufacturers need better expression systems and analytical tools to compete.

Biosimilars' Technology Needs

Biosimilar manufacturers need better expression systems and analytical tools to compete.
Nov 2, 2011

Biosimilar manufacturers need better expression systems and analytical tools to compete.

Offshoring Biomanufacturing

China rises to the top as a destination for international outsourcing.
Sep 8, 2011

China rises to the top as a destination for international outsourcing.

Offshoring Biomanufacturing

China rises to the top as a destination for international outsourcing.
Aug 2, 2011

China rises to the top as a destination for international outsourcing.

Wanted: Better Upstream Bioprocessing Technologies

A recent industry survey shows keen interest in improving bioreactors and cell-culture media.
Jul 12, 2011

A recent industry survey shows keen interest in improving bioreactors and cell-culture media.

Wanted: Better Upstream Bioprocessing Technologies

A recent industry survey shows keen interest in improving bioreactors and cell-culture media.
Jun 2, 2011

A recent industry survey shows keen interest in improving bioreactors and cell-culture media.

Changes Underway for Biopharmaceutical Outsourcing

More crucial biomanufacturing operations are expected to be outsourced.
Mar 2, 2011

More crucial biomanufacturing operations are expected to be outsourced.

Changes Underway for Biopharmaceutical Outsourcing

More crucial biomanufacturing operations are expected to be outsourced.
Feb 2, 2011

More crucial biomanufacturing operations are expected to be outsourced.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
FindPharma Custom Search
Click here